We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Security National Financial
SNFCA
$229M
| $5.64K | ﹤0.01% |
817
-731
| -47% | -$4.65K |
|
1827
Nature's Sunshine
NATR
$230M
| $5.53K | ﹤0.01% |
367
-87
| -19% | -$1.49K |
|
1828
Banco Santander
SAN
$213B
| $5.48K | ﹤0.01% |
1,184
| – | – |
|
1829
CAE Inc
CAE
$7.63B
| $5.41K | ﹤0.01% |
291
+33
| +13% | +$639 |
|
1830
Phibro Animal Health
PAHC
$1.42B
| $5.4K | ﹤0.01% |
322
+272
| +544% | +$4.37K |
|
1831
Business First Bancshares
BFST
$1.02B
| $5.4K | ﹤0.01% |
248
+195
| +368% | +$4.07K |
|
|
KZR
1832
DELISTED
Kezar Life Sciences
KZR
| $5.37K | ﹤0.01% |
895
-1,453
| -62% | -$11K |
|
1833
Dillards
DDS
$10B
| $5.29K | ﹤0.01% |
12
| – | – |
|
1834
Hudbay
HBM
$11.2B
| $5.16K | ﹤0.01% |
570
| – | – |
|
|
BCAB
1835
DELISTED
BIOATLA INC
BCAB
| $5.11K | ﹤0.01% |
+75
| New | +$8.92K |
|
1836
Varex Imaging
VREX
$778M
| $5.04K | ﹤0.01% |
342
-656
| -66% | -$10.5K |
|
|
CARM
1837
DELISTED
Carisma Therapeutics
CARM
| $5.03K | ﹤0.01% |
+3,312
| New | +$4.94K |
|
1838
LeMaitre Vascular
LMAT
$1.84B
| $5.02K | ﹤0.01% |
61
+27
| +79% | +$1.98K |
|
1839
Innospec
IOSP
$2.26B
| $4.94K | ﹤0.01% |
40
| – | – |
|
|
AIOT
1840
PowerFleet Inc
AIOT
$404M
| $4.94K | ﹤0.01% |
+1,080
| New | +$5.13K |
|
|
PPLI
1841
People Inc
PPLI
$2.85B
| $4.92K | ﹤0.01% |
128
-26
| -17% | -$1.07K |
|
1842
LSI Industries
LYTS
$748M
| $4.89K | ﹤0.01% |
338
-29
| -8% | -$438 |
|
1843
Sensus Healthcare
SRTS
$50.7M
| $4.84K | ﹤0.01% |
908
-41
| -4% | -$188 |
|
1844
Covenant Logistics
CVLG
$915M
| $4.78K | ﹤0.01% |
194
| – | – |
|
1845
WPP
WPP
$5.57B
| $4.76K | ﹤0.01% |
104
| – | – |
|
1846
Natural Gas Services Group
NGS
$466M
| $4.67K | ﹤0.01% |
232
+93
| +67% | +$2.04K |
|
1847
OneSpaWorld
OSW
$2.2B
| $4.63K | ﹤0.01% |
301
| – | – |
|
1848
Dave Inc
DAVE
$4.78B
| $4.58K | ﹤0.01% |
151
+132
| +695% | +$5.36K |
|
|
PSTL
1849
Postal Realty Trust
PSTL
$720M
| $4.53K | ﹤0.01% |
340
| – | – |
|
1850
American Superconductor
AMSC
$1.34B
| $4.51K | ﹤0.01% |
+193
| New | +$3.19K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.